drugset / Trial / NCT00828763
GSK1349572 Mass Balance Study
NaSingle-groupOpen-labelTreatment
Summary
Mass balance study to determine the recovery of a single radiolabelled dose of GSK1349572 from urine and feces
Timeline
- Start
- 2009-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dolutegravir | Other / unclassified | 20 mg | Oral |
Indications
No indication recorded.